Prognostic values of lipoprotein(a) levels for secondary prevention of acute coronary syndrome among patients who underwent primary percutaneous coronary intervention

被引：0
|
作者：
Okubo, R. [1 ]
Kishigami, D. [1 ]
Hirano, S. [1 ]
Sakurai, K. [1 ]
Tsubono, M. [1 ]
Oka, Y. [1 ]
Kojima, Y. [1 ]
Aikawa, H. [1 ]
Komatsu, Y. [1 ]
Noike, R. [1 ]
Yabe, T. [1 ]
Nakanishi, R. [1 ]
Amano, H. [1 ]
Ikeda, T. [1 ]
机构：
[1] Toho Univ, Fac Med, Dept Cardiovasc Med, Tokyo, Japan
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2783
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Plasma Lipoprotein(a) Predicts Long-term Bleeding in Patients with Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention
    Xu, Na
    Yuan, Jinqing
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C114 - C115
  • [2] Eligibility to Intensified Antithrombotic Regimens for Secondary Prevention in Patients Who Underwent Percutaneous Coronary Intervention
    Greco, Antonio
    Scilletta, Sabrina
    Faro, Denise Cristiana
    Agnello, Federica
    Mauro, Maria Sara
    Laudani, Claudio
    Occhipinti, Giovanni
    Spagnolo, Marco
    Rochira, Carla
    Finocchiaro, Simone
    Mazzone, Placido Maria
    Ammirabile, Nicola
    Landolina, Davide
    Imbesi, Antonino
    Capodanno, Davide
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 199
  • [3] Eligibility to Intensified Antithrombotic Regimens for Secondary Prevention in Patients Who Underwent Percutaneous Coronary Intervention
    Greco, Antonio
    Scilletta, Sabrina
    Faro, Denise Cristiana
    Agnello, Federica
    Mauro, Maria Sara
    Laudani, Claudio
    Occhipinti, Giovanni
    Spagnolo, Marco
    Rochira, Carla
    Finocchiaro, Simone
    Mazzone, Placido Maria
    Ammirabile, Nicola
    Landolina, Davide
    Imbesi, Antonino
    Capodanno, Davide
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 199 : 7 - 17
  • [4] Analysis of the dynamics and prognostic significance of inflammatory markers in patients with heart failure who underwent acute coronary syndrome and percutaneous coronary intervention
    Musikhina, N.
    Kostousova, A.
    Petelina, T.
    Gorbatenko, E.
    Gapon, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 62 - 62
  • [5] Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention
    Xu, Na
    Tang, Xiao-fang
    Yao, Yi
    Jia, Si-da
    Liu, Yue
    Zhao, Xue-yan
    Chen, Jue
    Gao, Zhan
    Yang, Yue-jin
    Gao, Run-lin
    Xu, Bo
    Yuan, Jin-qing
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (02) : 265 - 273
  • [6] Prognostic Value of the Clinical SYNTAX Score on 2-Year Outcomes in Patients With Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention
    He, Chen
    Song, Ying
    Wang, Chuang-shi
    Yao, Yi
    Tang, Xiao-fang
    Zhao, Xue-yan
    Gao, Run-lin
    Yang, Yue-jin
    Xu, Bo
    Yuan, Jin-qing
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (10): : 1493 - 1499
  • [7] Impact of Metabolic Syndrome on the Clinical Outcomes of Patients with Acute Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention
    Lee, Min Goo
    Ahn, Youngkeun
    Jeong, Myung Ho
    Chae, Shung Chull
    Kim, Young Jo
    Chae, Jei Keon
    Cho, Myeong Chan
    Kim, Chong Jin
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 131D - 131D
  • [8] Secondary prevention therapies following percutaneous coronary intervention or acute coronary syndrome in patients with diabetes mellitus
    Planchat, Arnaud
    Gencer, Baris
    Degrauwe, Sophie
    Musayeb, Yazan
    Roffi, Marco
    Iglesias, Juan F.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [9] The prognostic significance of statin therapy in acute myocardial infarction patients who underwent percutaneous coronary intervention
    Hong, YJ
    Jeong, MH
    Lim, JH
    Park, HW
    Kim, HG
    Park, OY
    Kim, JH
    Kim, W
    Ahn, YK
    Cho, J
    Park, JC
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 44L - 44L
  • [10] The benefits of bisoprolol were comparable with carvedilol in secondary prevention of acute myocardial infarction patients who underwent percutaneous coronary intervention
    Cho, S. C.
    Kang, W. Y.
    Hwang, S. H.
    Kim, W.
    Kang, D. G.
    Kim, S. H.
    Park, K. -H.
    Kim, W.
    Kim, S. S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1169 - 1169
12345